India: Responsive COVID-19 Vaccines for Recovery Project

approved

The project will support procurement of safe and effective vaccines against COVID-19. The proposed Loan will be co-financed with the Asian Development Bank (ADB) under its rapid response component (RRC) of ADB's Asia Pacific Vaccine Access Facility (APVAX). The loan proceeds of ADB and AIIB will finance expenditures in relation to the procurement of COVID-19 vaccines that meet the APVAX eligibility criteria. The GoI will cover financial charges during implementation, including interest, commitment charges and front-end fees. In parallel to this Project, ADB has mobilized around USD 4 million for technical assistance to provide catalytic operational support through the program management unit, monitoring of vaccination sites, strengthening biomedical waste management capacity, supporting private sector engagement, increasing awareness and willingness of vaccination among the vulnerable groups, and strengthening capacity for monitoring and addressing the adverse events after immunization.